Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10632180
Methods and compositions for improved cognition
granted -
US 10632152
Chimeric antigen receptor and methods of use thereof
granted -
US 10632092
Composition for and method to increase serum adiponectin and reduce body fat
granted -
US 10632088
Inactivators of Toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria
granted -
US 10632101
Methods and compositions for supporting endogenous systems related to life span
granted -
US 10632091
Dosage forms and therapeutic uses of L-4-chlorokynurenine
granted -
US 10632070
Hydrogel toxin-absorbing or binding nanoparticles
granted -
US 10631559
Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-(3S,6S)-
granted -
US 10632072
Systems and methods for continuous manufacturing of liposomal drug formulations
granted -
US 10633351
Halogenated compound and axially chiral isomer thereof
granted -
CA 3116885
COMPOSITIONS ET METHODES D'ADMINISTRATION DE TRANSGENE
granted -
US 10626399
Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
granted -
US 10624959
Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
granted -
US 10626146
α4β7 thioether peptide dimer antagonists
granted -
US 10626129
Heteroaryl inhibitors of PDE4
granted -
US 10626469
Rapid identification of microorganisms
granted -
US 10626094
Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof
granted -
US 10624849
Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
granted -
US 10624887
Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14,-diol
granted -
US 10624850
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
granted -
US 10627409
Therapeutic antibodies against ROR-1 protein and methods for use of same
granted -
US 10626393
Delivering CRISPR therapeutics with lipid nanoparticles
granted -
US 10626145
Peptide with anti-obesity and anti-diabetes activity and use thereof
granted -
US 10626419
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.